APA (7th ed.) Citation

Gagliardini, R., Camici, M., Lanini, S., Bellagamba, R., Ottou, S., Plazzi, M. M., . . . Antinori, A. (2025). Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: Findings from a non-randomized clinical trial (EBONY study). Elsevier.

Chicago Style (17th ed.) Citation

Gagliardini, Roberta, et al. Switching to Bictegravir/emtricitabine/tenofovir Alafenamide from Efavirenz/emtricitabine/tenofovir Disoproxil in Virologically Suppressed People with HIV: Findings from a Non-randomized Clinical Trial (EBONY Study). Elsevier, 2025.

MLA (9th ed.) Citation

Gagliardini, Roberta, et al. Switching to Bictegravir/emtricitabine/tenofovir Alafenamide from Efavirenz/emtricitabine/tenofovir Disoproxil in Virologically Suppressed People with HIV: Findings from a Non-randomized Clinical Trial (EBONY Study). Elsevier, 2025.